Black Diamond Therapeutics, Inc. - BDTX

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$83M

QoQ value delta ($000)

+$10.35M (+14.24%)

Implied price effect (QoQ)

-11.66%

Total shares

38,677,313

QoQ shares delta

+8,768,399 (+29.32%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 99 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
T. Rowe Price Investment Management, Inc.	22,500	10,563,103	0.02%
NEA Management Company, LLC	9,475	4,448,757	0.54%
VANGUARD GROUP INC	5,318	2,188,857	0.0%
ACADIAN ASSET MANAGEMENT LLC	4,997	2,348,651	0.01%
RENAISSANCE TECHNOLOGIES LLC	3,501	1,643,747	0.01%
DIMENSIONAL FUND ADVISORS LP	2,772	1,301,664	0.0%
BlackRock, Inc.	2,357	1,106,840	0.0%
Connor, Clark & Lunn Investment Management Ltd.	2,254	1,058,397	0.01%
MACKENZIE FINANCIAL CORP	1,799	844,835	0.0%
MARSHALL WACE, LLP	1,781	836,266	0.0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	1,777	834,570	0.0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC	1,541	723,477	0.03%
GOLDMAN SACHS GROUP INC	1,457	684,418	0.0%
FMR LLC	1,328	623,827	0.0%
CITADEL ADVISORS LLC	1,287	604,552	0.0%
UBS Group AG	1,203	564,838	0.0%
Man Group plc	1,192	559,700	0.0%
WINTON GROUP Ltd	1,146	538,259	0.04%
GEODE CAPITAL MANAGEMENT, LLC	1,143	536,575	0.0%
AWM Investment Company, Inc.	1,118	525,000	0.12%
BALYASNY ASSET MANAGEMENT L.P.	1,088	510,811	0.0%
NORTHERN TRUST CORP	989	464,708	0.0%
D. E. Shaw & Co., Inc.	775	363,921	0.0%
GLOBEFLEX CAPITAL L P	650	305,276	0.1%
STIFEL FINANCIAL CORP	593	278,645	0.0%